TECH logo

Bio-Techne (TECH)

Profile

Full Name

Bio-Techne Corporation

Ticker Symbol

TECH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 9, 1989

Indexes

S&P 500

Website

http://www.bio-techne.com

Employees

3100

Key Details

Price

$52.08(+1.22%)

Market cap

$8.16B(Mid cap)

Last Dividend

$0.08

TTM Dividend yield

0.61%

Annual revenue

$1.16B(+1.97% YoY)

Annual EPS

$1.05(-40.34% YoY)

PE ratio

63.51

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $52.08
    TECH price is $52.08

    30-Day Relative Volume

    1.02
    TECH 30-day relative volume is 1.02

    Price Performance

    Price Most recent change

    +1.22%
    TECH price was up +1.22% on Jul 1, 2025

    Price YTD change

    -27.7%
    TECH price is down -27.7% since January 1st

    Price 1-year change

    -26.9%
    TECH price is down -26.9% year-on-year

    Price 3-year change

    -41.02%
    TECH price is down -41.02% over the past 3 years

    Price Range

    Price All-time high

    $135.96
    TECH price is currently -61.70% below its historical high of $135.96

    Price 3-year low

    $46.01
    TECH price is currently +13.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.16B
    TECH market capitalization is $8.16 billion

    Market cap 3-year change

    -40.97%
    TECH market capitalization is down -40.97% over the past 3 years

    Market cap All-time high

    $21.14B
    TECH market capitalization is currently -61.39% below its historical high of $21.14 billion

    Market cap sector rank

    91.57%
    TECH market capitalization is higher than 91.57% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.92%
    TECH shares outstanding is down -0.92% year-on-year

    Shares Outstanding 3-Year Change

    +0.08%
    TECH shares outstanding is up +0.08% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.17
    TECH beta is 1.17

    200-day SMA

    $64.66
    TECH price is currently -19.46% below its 200-day simple moving average

    50-day SMA

    $49.77
    TECH price is currently +4.65% above its 50-day simple moving average

    RSI

    56.43
    TECH 14-day relative strength index is 56.43

    Volume

    1.02
    TECH 30-day relative volume is 1.02

    ATR

    $2.12
    TECH average true range is $2.12

    10-day Historical Volatility

    35.46%
    TECH 10-day historical volatility is 35.46%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.08
    TECH last dividend was $0.08 per share, with an ex-dividend date of May 19, 2025

    Next Dividend

    -
    TECH next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $0.32
    TECH annual dividend per share is $0.32

    Dividend per share Sector Rank

    17.65%
    TECH annual dividend per share is higher than 17.65% of companies in Healthcare sector

    Dividend per share 1-Year Change

    0%
    TECH {parameterFullLabel} has remained unchanged year-on-year

    Dividend per share 3-Year Change

    0%
    TECH {parameterFullLabel} has remained unchanged over the past 3 years

    Dividend yield

    Dividend yield

    0.61%
    TECH annual dividend yield is 0.61%

    Dividend yield Sector Rank

    17.86%
    TECH annual dividend yield is higher than 17.86% of companies in Healthcare sector

    Other

    Payout ratio

    29.99%
    TECH annual payout ratio is 29.99%

    Dividends paid

    $50.42M
    TECH annual dividends paid is $50.42 million

    Free cash flow

    $236.10M
    TECH annual free cash flow is $236.10 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.16B
    TECH annual revenue is $1.16 billion

    Revenue Analysts estimate

    $1.22B
    TECH annual revenue is currently -5.02% lower than the consensus analysts' forecast

    Revenue 1-year change

    +1.97%
    TECH annual revenue is up +1.97% year-on-year

    Revenue Sector rank

    81.24%
    TECH annual revenue is higher than 81.24% of companies in Healthcare sector

    EPS

    EPS

    $1.05
    TECH annual earnings per share is $1.05

    EPS Analysts estimate

    $1.91
    TECH annual earnings per share is currently -45.06% lower than the consensus analysts' forecast

    EPS 1-year change

    -40.34%
    TECH annual earnings per share is down -40.34% year-on-year

    EPS Sector rank

    89.54%
    TECH annual earnings per share is higher than 89.54% of companies in Healthcare sector

    Profit

    Gross profit

    $769.73M
    TECH annual gross profit is $769.73 million

    Gross margin

    66.41%
    TECH annual gross profit margin is 66.41%

    Operating profit

    $206.69M
    TECH annual operating income is $206.69 million

    Operating margin

    17.83%
    TECH annual operating profit margin is 17.83%

    Net income

    $168.10M
    TECH annual net profit is $168.10 million

    Net margin

    14.50%
    TECH annual net profit margin is 14.50%

    Expenses

    Total expenses

    $952.37M
    TECH annual total expenses is $952.37 million

    Operating expenses

    $563.04M
    TECH annual total operating expenses is $563.04 million

    Cost of goods sold

    $389.33M
    TECH annual cost of goods sold is $389.33 million

    Selling, general & administrative expenses

    $466.38M
    TECH annual SGA is $466.38 million

    Depreciation and amortization

    $111.71M
    TECH annual depreciation & amortization is $111.71 million

    Interest expense

    $15.74M
    TECH annual interest expense is $15.74 million

    Income tax

    $17.58M
    TECH annual income tax is $17.58 million

    EBIT & EBITDA

    EBIT

    $206.69M
    TECH annual earnings before interest & taxes is $206.69 million

    EBITDA

    $318.40M
    TECH annual EBITDA is $318.40 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.70B
    TECH annual total assets is $2.70 billion

    Non current assets

    $2.09B
    TECH annual long term assets is $2.09 billion

    Current assets

    $617.42M
    TECH annual total current assets is $617.42 million

    Cash and cash equivalents

    $151.79M
    TECH annual cash & cash equivalents is $151.79 million

    Accounts receivable

    $241.39M
    TECH annual accounts receivable is $241.39 million

    Inventory

    $179.73M
    TECH annual inventory is $179.73 million

    Liabilities

    Total liabilities

    $635.02M
    TECH annual total liabilities is $635.02 million

    Long term liabilities

    $475.64M
    TECH annual total long term liabilities is $475.64 million

    Current liabilities

    $159.38M
    TECH annual total current liabilities is $159.38 million

    Accounts payable

    $37.97M
    TECH annual accounts payable is $37.97 million

    Debt

    Total debt

    $419.54M
    TECH annual total debt is $419.54 million

    Total debt 1-year change

    -7.79%
    TECH annual total debt is down -7.79% year-on-year

    Long term debt

    $406.62M
    TECH annual long term debt is $406.62 million

    Short term debt

    $12.92M
    TECH annual short term debt is $12.92 million

    Equity & Capital

    Shareholders equity

    $2.07B
    TECH annual stockholders equity is $2.07 billion

    Book value

    $2.07B
    TECH annual book value is $2.07 billion

    Retained earnings

    $1.33B
    TECH annual retained earnings is $1.33 billion

    Working capital

    $458.04M
    TECH annual working capital is $458.04 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $298.98M
    TECH annual cash flow from operations is $298.98 million

    Cash from operations 1-year change

    +17.53%
    TECH annual cash flow from operations is up +17.53% year-on-year

    Cash from investing

    -$203.03M
    TECH annual cash flow from investing activities is -$203.03 million

    Cash from investing 1-year change

    +23.57%
    TECH annual cash flow from investing activities is up +23.57% year-on-year

    Cash from financing

    -$122.40M
    TECH annual cash flow from financing activities is -$122.40 million

    Cash from financing 1-year change

    -641.2%
    TECH annual cash flow from financing activities is down -641.2% year-on-year

    CAPEX

    CAPEX

    $62.88M
    TECH annual capital expenditures is $62.88 million

    CAPEX 1-year change

    +64.41%
    TECH annual capital expenditures is up +64.41% year-on-year

    Free Cash Flow

    Free cash flow

    $236.10M
    TECH annual free cash flow is $236.10 million

    Free cash flow 1-year change

    +9.23%
    TECH annual free cash flow is up +9.23% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    66.41%
    TECH annual gross profit margin is 66.41%

    Operating margin

    17.83%
    TECH annual operating profit margin is 17.83%

    Net margin

    14.50%
    TECH annual net profit margin is 14.50%

    ROA & ROE

    ROA

    6.29%
    TECH annual return on assets is 6.29%

    ROE

    8.33%
    TECH annual return on equity is 8.33%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    63.51
    TECH price to earnings ratio is 63.51

    PE ratio Sector rank

    86.45%
    TECH price to earnings ratio is higher than 86.45% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.05
    TECH price to book ratio is 4.05

    PB ratio Sector rank

    76.66%
    TECH price to book ratio is higher than 76.66% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.75
    TECH price to sales ratio is 6.75

    PS ratio Sector rank

    70.73%
    TECH price to sales ratio is higher than 70.73% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $8.45B
    TECH enterprise value is $8.45 billion

    Enterprise value Sector rank

    90.84%
    TECH enterprise value is higher than 90.84% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    29.88
    TECH EV/EBITDA is 29.88

    EV/EBITDA Sector rank

    94.25%
    TECH EV/EBITDA is higher than 94.25% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.87
    TECH annual current ratio is 3.87

    Quick ratio

    2.75
    TECH annual quick ratio is 2.75

    Leverage

    Debt to equity

    0.15
    TECH annual debt to equity ratio is 0.15

    Interest coverage ratio

    13.13
    TECH annual interest coverage ratio is 13.13

    Risk & Stability

    Piotroski F-Score

    8
    TECH piotroski f-score is 8

    Altman Z-Score

    9.28
    TECH altman z-score is 9.28

    Analyst ratings

    Recent major analysts updates

    Jun 5, 25 Benchmark
    Buy
    May 30, 25 Wells Fargo
    Overweight
    May 9, 25 UBS
    Buy
    May 8, 25 Stifel
    Hold
    May 8, 25 RBC Capital
    Sector Perform
    May 8, 25 Benchmark
    Buy
    Apr 9, 25 Keybanc
    Sector Weight
    Apr 8, 25 Keybanc
    Sector Weight
    Mar 18, 25 Evercore ISI Group
    Outperform
    Mar 4, 25 Citigroup
    Neutral

    Institutional Ownership

    Screeners with TECH included

    Mid cap stocks
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    • What is the ticker symbol for Bio-Techne?
    • Does Bio-Techne pay dividends?
    • What sector is Bio-Techne in?
    • What industry is Bio-Techne in?
    • What country is Bio-Techne based in?
    • When did Bio-Techne go public?
    • Is Bio-Techne in the S&P 500?
    • Is Bio-Techne in the NASDAQ 100?
    • Is Bio-Techne in the Dow Jones?
    • When was Bio-Techne's last earnings report?
    • When does Bio-Techne report earnings?
    • Should I buy Bio-Techne stock now?

    What is the ticker symbol for Bio-Techne?

    The ticker symbol for Bio-Techne is NASDAQ:TECH

    Does Bio-Techne pay dividends?

    Yes, Bio-Techne pays dividends. The last payment was $0.08, with an ex-dividend date on May 19, 2025

    What sector is Bio-Techne in?

    Bio-Techne is in the Healthcare sector

    What industry is Bio-Techne in?

    Bio-Techne is in the Biotechnology industry

    What country is Bio-Techne based in?

    Bio-Techne is headquartered in United States

    When did Bio-Techne go public?

    Bio-Techne's initial public offering (IPO) was on February 9, 1989

    Is Bio-Techne in the S&P 500?

    Yes, Bio-Techne is included in the S&P 500 index

    Is Bio-Techne in the NASDAQ 100?

    No, Bio-Techne is not included in the NASDAQ 100 index

    Is Bio-Techne in the Dow Jones?

    No, Bio-Techne is not included in the Dow Jones index

    When was Bio-Techne's last earnings report?

    Bio-Techne's most recent earnings report was on May 7, 2025

    When does Bio-Techne report earnings?

    The next expected earnings date for Bio-Techne is Aug 7, 2025

    Should I buy Bio-Techne stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page